Home » Topics » Regulatory

Regulatory
RSS

Orphan Medical licenses rights to butamben

April 29, 2002

Faslodex approved in U.S. for tamoxifen-resistant breast cancer

April 29, 2002

MediGene submits MAA in Germany for Eligard 22.5 mg

April 26, 2002

Periostat approved in Austria and Finland

April 26, 2002

Prefilled syringe presentation of Copaxone launched

April 26, 2002

Xalatan approved in E.U. as first-line therapy for lowering IOP in glaucoma patients

April 24, 2002

Paxil CR launched in U.S.

April 23, 2002

Altocor filed for European marketing approval

April 22, 2002

FDA approves Botox Cosmetic for treatment of glabellar lines

April 19, 2002

NDA submitted for Eligard 30 mg for advanced prostate cancer

April 18, 2002

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...